The implications of WTO accession on the pharmaceutical industry in China

Journal of Contemporary China

Volumn 11, Issue 32, 2002, Pages 473-493

  Yeung, Godfrey ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INDUSTRIAL COMPETITION; INDUSTRIAL PERFORMANCE; PHARMACEUTICAL INDUSTRY; RESEARCH AND DEVELOPMENT; TARIFF STRUCTURE; WORLD TRADE ORGANIZATION;

CHINA;

EID: 0036687506     PISSN: 10670564     EISSN: None     Source Type: Journal    
DOI: 10.1080/10670560220152292     Document Type: Article

References (29)

1. On the complexities of China's WTO accession
2. Behind China's world trade organization agreement with the USA
3. China's WTO accession: The economics and politics
4. Domestic politics and the US - China WTO agreement
5. Opening China's bond market-catalyst to further reform and a jumpstart to the stalled WTO accession negotiations
6. China's WTO accession-commitments and prospects
7. Applying GATT to marketizing economies: The dilemma of WTO accession and reform of China's State-Owned Enterprises (SOEs)
8. Health care reform, foreign direct investment and their impact on the pharmaceutical industry in China
9. Organizational processes to meet new performance criteria: Chinese pharmaceutical firms in transition
10. Globalisation, industrial concentration and catch-up in pharmaceuticals: The case of China's Sanjiu group
11. The demand for medical care in urban China
12. On the issues of population ageing and population control in China
13. Tradition at risk